Artificial Hip Joints – Archives

• Biomet Receives FDA Approval for Ceramic-On-Ceramic Hip System
  Biomet Inc. announced today that the U.S. Food & Drug Administration has issued an approval order for the Company's C2a-Taper(TM) Acetabular System, featuring ceramic-on-ceramic articulation and Biomet's Porous Plasma Spray (PPS(TM)) technology. The product launch will commence immediately.
  Author: Dane Miller - Date: 04/06/2006



• Portland Orthopaedics Lodges FDA Application To Implant New Primary Hip Replacements
  Sydney-based Portland Orthopaedics Limited (ASX: PLD) has lodged an application with the US Food and Drug Administration (FDA) for approval to market the company's new M-COR primary hip product range in patients in the US. Portland Orthopaedics received its first FDA approval for the DTC Hip in 2000 and in 2005 was granted FDA approval for use of its second product, the Equator Plus Cup.
  Author: David Sekel - Date: 19/02/2006



• Biomet Receives FDA Approval for Ceramic-On-Ceramic Hip System
  Biomet Inc. (NASDAQ:BMET) announced today that the U.S. Food & Drug Administration has issued an approval order for the Company's C2a-Taper(TM) Acetabular System, featuring ceramic-on-ceramic articulation and Biomet's Porous Plasma Spray (PPS(TM)) technology. The product launch will commence immediately.
  Author: Jeff Nagel - Date: 08/02/2006